T1	PROC 46 60	Ensayo clínico
#1	AnnotatorNotes T1	C0008976; Clinical Trials; Research Activity
T2	CHEM 105 122	aceite de pescado
#2	AnnotatorNotes T2	C0016157; fish oils; Organic Chemical · Pharmacologic Substance
T3	PROC 208 255	ENSAYO CLÍNICO PILOTO, RANDOMIZADO, DOBLE CIEGO
T4	CHEM 329 346	ACEITE DE PESCADO
T5	DISO 446 466	neoplasia de esófago
T6	PROC 353 372	SOPORTE NUTRICIONAL
#3	AnnotatorNotes T6	C0242739; Nutritional Support; Therapeutic or Preventive Procedure
T7	PROC 542 556	diagnosticados
#4	AnnotatorNotes T7	C0011900; Diagnosis; Diagnostic Procedure
T8	DISO 560 577	cáncer de esofágo
T9	PROC 610 623	esofagectomía
#5	AnnotatorNotes T9	C0085198; Esophagectomy; Therapeutic or Preventive Procedure
T10	PROC 810 824	CI por escrito
#6	AnnotatorNotes T10	C0811741; Obtain informed written consent; Health Care Activity
T11	PROC 899 913	CI por escrito
#7	AnnotatorNotes T11	C0811741; Obtain informed written consent; Health Care Activity
T12	ANAT 1017 1031	tubo digestivo
#8	AnnotatorNotes T12	C0017189; Gastrointestinal tract structure; Body System | C4516948; Entire digestive tract; Body System
T13	PROC 1424 1465	Tratados con corticoides de forma crónica
T14	DISO 1201 1228	hipersensibilidad de tipo I
#9	AnnotatorNotes T14	C0020523; Immediate hypersensitivity; Pathologic Function | C0429892; Type 1 hypersensitivity response; Pathologic Function
T15	CHEM 1289 1309	emulsiones lipídicas
#10	AnnotatorNotes T15	C3883356; Lipid Emulsion; Pharmacologic Substance
T16	PROC 386 403	ESOFAGECTOMIZADOS
T17	CHEM 1384 1397	triglicéridos
#11	AnnotatorNotes T17	C0041004; Triglycerides; Biologically Active Substance · Organic Chemical
T18	ANAT 1398 1409	plasmáticos
#12	AnnotatorNotes T18	C0032105; Plasma; Body Substance
T19	CHEM 1437 1448	corticoides
#13	AnnotatorNotes T19	C0001617; Adrenal Cortex Hormones; Hormone · Organic Chemical · Pharmacologic Substance
T20	CHEM 1468 1484	inmunosupresores
#14	AnnotatorNotes T20	C0021081; Immunosuppressive Agents; Immunologic Factor · Pharmacologic Substance
T21	DISO 1515 1519	SIDA
#15	AnnotatorNotes T21	C0001175; Acquired Immunodeficiency Syndrome; Disease or Syndrome
T22	PROC 1526 1539	trasplantados
#16	AnnotatorNotes T22	C0040732; Transplantation; Therapeutic or Preventive Procedure
T23	DISO 1545 1564	Disfunción hepática
#17	AnnotatorNotes T23	C0086565; Liver Dysfunction; Finding
T24	DISO 1637 1661	enfermedad descompensada
T25	PROC 168 185	esofagectomizados
T26	ANAT 459 466	esófago
#18	AnnotatorNotes T26	C0014876; Esophagus; Body Part, Organ, or Organ Component | C1278919; Entire esophagus; Body Part, Organ, or Organ Component
T27	ANAT 570 577	esofágo
T28	PROC 89 100	suplementar
#19	AnnotatorNotes T28	C0242297; Dietary Supplementation; Therapeutic or Preventive Procedure
T29	DISO 1235 1261	reacciones idiosincrásicas
#20	AnnotatorNotes T29	C0745213; idiosyncratic reaction; Finding
T30	PROC 1384 1409	triglicéridos plasmáticos
T31	ANAT 1556 1564	hepática
#21	AnnotatorNotes T31	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T32	PROC 428 441	Esofagectomía
#22	AnnotatorNotes T32	C0085198; Esophagectomy; Therapeutic or Preventive Procedure
T33	PROC 287 312	SUPLEMENTACIÓN PARENTERAL
#23	AnnotatorNotes T33	C1882290; Parenteral Therapeutic Nutritional Supplementation; Therapeutic or Preventive Procedure
T34	PROC 632 664	técnicas de Ivor-Lewis o MacEwan
T35	Date 13 17	2016
T36	Route 123 134	intravenoso
#24	AnnotatorNotes T36	C1522726; Intravenous Route of Drug Administration; Functional Concept
T37	LIVB 158 167	pacientes
#25	AnnotatorNotes T37	C0030705; Patients; Patient or Disabled Group
T38	Route 302 312	PARENTERAL
#26	AnnotatorNotes T38	C1518896; Parenteral Route of Drug Administration; Functional Concept
T39	Form 317 325	EMULSIÓN
T41	LIVB 376 385	PACIENTES
#27	AnnotatorNotes T41	C0030705; Patients; Patient or Disabled Group
T42	LIVB 532 541	pacientes
#28	AnnotatorNotes T42	C0030705; Patients; Patient or Disabled Group
T43	Age 716 738	Edad mínima de 18 años
T44	LIVB 743 754	ambos sexos
#29	AnnotatorNotes T44	C0025266; Male population group; Population Group + C0043210; Woman; Population Group
T46	LIVB 872 878	sujeto
#30	AnnotatorNotes T46	C0681850; Study Subject; Group
T48	LIVB 955 974	representante legal
#31	AnnotatorNotes T48	C4288823; Legal Representative for the Study; Human
T49	Neg_cue 1058 1060	No
T50	LIVB 1100 1109	pacientes
#32	AnnotatorNotes T50	C0030705; Patients; Patient or Disabled Group
T53	Form 1289 1299	emulsiones
T54	Route 1310 1322	intravenosas
#33	AnnotatorNotes T54	C1522726; Intravenous Route of Drug Administration; Functional Concept
T55	LIVB 1328 1373	Mujeres embarazadas o en período de lactancia
#34	AnnotatorNotes T55	C0033011; Pregnant Women; Population Group | C4316174; Patients who are breastfeeding; Patient or Disabled Group
T57	Duration 1458 1465	crónica
#35	AnnotatorNotes T57	C0205191; chronic; Temporal Concept
T58	Date 1488 1501	el mes previo
T40	PHYS 1364 1373	lactancia
#36	AnnotatorNotes T40	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T45	PHYS 1336 1347	embarazadas
#37	AnnotatorNotes T45	C0032961; Pregnancy; Organism Function
T51	PROC 1570 1580	Child-Pugh
#38	AnnotatorNotes T51	C3854424; Child-Pugh-Turcotte score; Laboratory Procedure
A2	Assertion T50 Negated
A3	Status T14 History_of
A4	Status T29 History_of
A5	Status T20 History_of
A6	Status T22 History_of
#39	AnnotatorNotes T3	C0031928; Pilot Projects; Research Activity + C0034656; Randomization; Research Activity + C0013072; Double-Blind Method; Research Activity
#40	AnnotatorNotes T16	C0085198; Esophagectomy; Therapeutic or Preventive Procedure
#41	AnnotatorNotes T25	C0085198; Esophagectomy; Therapeutic or Preventive Procedure
#42	AnnotatorNotes T8	C0546837; Malignant neoplasm of esophagus; Neoplastic Process 
#43	AnnotatorNotes T5	C0546837; Malignant neoplasm of esophagus; Neoplastic Process 
#44	AnnotatorNotes T30	C0583329; Plasma triglyceride measurement; Laboratory Procedure 
R1	Used_for Arg1:T2 Arg2:T28	
T47	Observation 79 85	efecto
#45	AnnotatorNotes T47	C1518681; Outcome of Therapy; Finding (?)
R2	Causes Arg1:T28 Arg2:T47	
R3	Has_Route_or_Mode Arg1:T2 Arg2:T36	
R4	Experiences Arg1:T37 Arg2:T25	
R6	Experiences Arg1:T37 Arg2:T47	
R7	Experiences Arg1:T37 Arg2:T28	
T52	Observation 274 280	EFECTO
#46	AnnotatorNotes T52	C1518681; Outcome of Therapy; Finding (?)
R8	Causes Arg1:T33 Arg2:T52	
R9	Has_Drug_Form Arg1:T4 Arg2:T39	
R10	Has_Route_or_Mode Arg1:T4 Arg2:T38	
R11	Used_for Arg1:T4 Arg2:T33	
#47	AnnotatorNotes T39	C4520839; Emulsion (basic dose form); Biomedical or Dental Material
R12	Overlap Arg1:T33 Arg2:T6	
R15	Overlap Arg1:T6 Arg2:T16	
R16	Experiences Arg1:T41 Arg2:T52	
R17	Experiences Arg1:T41 Arg2:T33	
R18	Experiences Arg1:T41 Arg2:T6	
R19	Experiences Arg1:T41 Arg2:T16	
R20	Location_of Arg1:T26 Arg2:T5	
R21	Location_of Arg1:T26 Arg2:T32	
#48	AnnotatorNotes T53	C4520839; Emulsion (basic dose form); Biomedical or Dental Material
R22	Has_Route_or_Mode Arg1:T15 Arg2:T54	
R23	Has_Drug_Form Arg1:T15 Arg2:T53	
R24	Negation Arg1:T49 Arg2:T50	
T56	CONC 1067 1076	incluidos
A1	Assertion T56 Negated
#49	AnnotatorNotes T56	C1512693; Inclusion; Qualitative Concept
R25	Negation Arg1:T49 Arg2:T56	
R26	Experiences Arg1:T42 Arg2:T8	
#50	AnnotatorNotes T27	C0014876; Esophagus; Body Part, Organ, or Organ Component | C1278919; Entire esophagus; Body Part, Organ, or Organ Component
R27	Location_of Arg1:T27 Arg2:T8	
R28	Experiences Arg1:T42 Arg2:T9	
R29	Overlap Arg1:T9 Arg2:T34	
T59	Observation 670 710	cumplan TODOS los criterios de inclusión
#51	AnnotatorNotes T59	C4329786; Eligibility Criteria Met By Subject; Finding (?)
R30	Has_Age Arg1:T44 Arg2:T43	
T60	Observation 786 796	Dispuestos
#52	AnnotatorNotes T60	C0600109; Willing; Finding
R31	Overlap Arg1:T60 Arg2:T10	
T61	Observation 846 853	capaces
#53	AnnotatorNotes T61	C1299581; Able (finding); Finding (?) | C1555472; Authorized; Finding (?)
R32	Overlap Arg1:T10 Arg2:T61	
T62	Observation 1000 1031	vía de acceso al tubo digestivo
R33	Causes Arg1:T15 Arg2:T14	
R34	Causes Arg1:T15 Arg2:T29	
R35	Experiences Arg1:T55 Arg2:T45	
R36	Experiences Arg1:T55 Arg2:T40	
R37	Location_of Arg1:T18 Arg2:T30	
T63	Result_or_Value 1410 1419	>3 mmol/L
R38	Has_Result_or_Value Arg1:T30 Arg2:T63	
R39	Has_Duration_or_Interval Arg1:T19 Arg2:T57	
R40	Used_for Arg1:T19 Arg2:T13	
R41	Used_for Arg1:T20 Arg2:T13	
R42	Overlap Arg1:T20 Arg2:T58	
R43	Overlap Arg1:T19 Arg2:T58	
R44	Location_of Arg1:T31 Arg2:T23	
T64	Result_or_Value 1581 1588	grado B
R46	Has_Result_or_Value Arg1:T51 Arg2:T64	
T65	Observation 1590 1624	compromiso funcional significativo
R47	Overlap Arg1:T23 Arg2:T65	
R48	Overlap Arg1:T23 Arg2:T24	
T66	Result_or_Value 1628 1635	grado C
R49	Has_Result_or_Value Arg1:T51 Arg2:T66	
R50	Experiences Arg1:T42 Arg2:T34	
R5	Overlap Arg1:T28 Arg2:T25	
R13	Overlap Arg1:T33 Arg2:T16	
#54	AnnotatorNotes T4	C0016157; fish oils; Organic Chemical · Pharmacologic Substance
A7	Experiencer T55 Patient
A8	Experiencer T37 Patient
A9	Experiencer T41 Patient
A10	Experiencer T42 Patient
A11	Experiencer T44 Patient
A12	Experiencer T46 Patient
A13	Experiencer T48 Other
A14	Experiencer T50 Patient
